Not applicableWithdrawnNCT04306861What this trial is testingNovel MRI Techniques for Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma Beth Israel Deaconess Medical Center
Not applicableLooking for participantsNCT07660627What this trial is testingDetermining Minimal Residual Disease Using ctDNA Deep SequencingWho this might be right forEsophageal AdenocarcinomaGastric CancerPancreatic Cancer Masaryk Memorial Cancer Institute 34
Large-scale testing (Phase 3)Looking for participantsNCT06714604What this trial is testingStandard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPCWho this might be right forLocally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas Cancer+3 more Sahlgrenska University Hospital 432
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748611What this trial is testingSMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC TrialWho this might be right forBorderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma Northwestern University 125
Testing effectiveness (Phase 2)Looking for participantsNCT06944106What this trial is testingA Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)Study completedNCT01068327What this trial is testingStereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasStage III Pancreatic Cancer University of Nebraska 46
Testing effectiveness (Phase 2)Study completedNCT02047513What this trial is testingNeoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic CancerWho this might be right forResectable Pancreatic CancerDuctal Adenocarcinoma of the Pancreas AIO-Studien-gGmbH 127
Testing effectiveness (Phase 2)Study completedNCT03727880What this trial is testingStudy of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal AdenocarcinomaWho this might be right forResectable Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma Lei Zheng 28
Testing effectiveness (Phase 2)Study completedNCT00609336What this trial is testingPerioperative Therapy for Resectable Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more University of Washington 35
Early research (Phase 1)Study completedNCT01918644What this trial is testingNeoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic CancerWho this might be right forStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic Cancer+1 more University of Wisconsin, Madison 21
Testing effectiveness (Phase 2)UnknownNCT06467565What this trial is testingNALIRIFOX as Induction Therapy in LAPCWho this might be right forPancreatic Ductal Adenocarcinoma The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06587061What this trial is testingHRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerWho this might be right forPancreatic Cancer Ruijin Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT01419002What this trial is testingStudy to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head CancerWho this might be right forPancreatic Adenocarcinoma CHIR-Net 5
Testing effectiveness (Phase 2)Study completedNCT02178709What this trial is testingA Phase II Study of Neoadjuvant FOLFIRINOXWho this might be right forResectable Pancreatic Ductal Adenocarcinoma Indiana University 48
Not applicableUnknownNCT05511116What this trial is testingNeoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRIWho this might be right forPancreas CancerAdenocarcinoma Fondation Hôpital Saint-Joseph 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07155629What this trial is testingNeoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic CancerWho this might be right forPancreatic Cancer Resectable Helsinki University Central Hospital 381
Testing effectiveness (Phase 2)Ended earlyNCT02241551What this trial is testingPhase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic CancerWho this might be right forBorderline Resectable Pancreatic Cancer Nathan Bahary, MD 2
Testing effectiveness (Phase 2)Study completedNCT00438256What this trial is testingNeoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic CancerWho this might be right forPancreatic Cancer Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00490360What this trial is testingNeoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic HeadWho this might be right forCancer of the Pancreatic Head University of Zurich 2,007
Testing effectiveness (Phase 2)WithdrawnNCT05415917What this trial is testingAdjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant ChemotherapyWho this might be right forPancreatic Cancer Rutgers, The State University of New Jersey